30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Maryles Joel Michael

Insider profile

Performance

Overall performance
1.4

Performance over holding periods
1.4
30 days 90 days 120 days
Average return -3% 8.2% 15.1%
Success rate 22% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Maryles Joel Michael's trades of Chemomab Therapeutics Ltd's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2022-05-25 2022-05-24 B Purchase
92,752 -32.8%
420.89
US$4,158,236
92,752 -32.8% 420.89 US$4,158,236
2022-05-25 2022-05-24 B Purchase
44,919 -35.3%
219.28
US$4,534,917
44,919 -35.3% 219.28 US$4,534,917
2022-03-21 2022-03-18 B Purchase
72,244 +6.8%
128.51
US$2,058,026
72,244 +6.8% 128.51 US$2,058,026
2022-03-21 2022-03-18 B Purchase
500 +inf%
4.32
US$2,160
500 +inf% 4.32 US$2,160